PCT Patent Application published
17. March 2022
Inventor: Dr. Matthias Grill
WO2022053696 - Novel Safrylamine derivates having prodrug properties
Video Interview with Dr. Matthias Grill
09. March 2022
In a video Interview, Dr. Matthias Grill is talking about the MiHKAL company and the collaboration with COMPASS
MiHKAL highlighted in annual report of COMPASS Pathways
24. February 2022
COMPASS pathways announces financial results for the year 2021 and is highlighting the pipeline development with MiHKAL GmbH
PCT Patent Application published
24. February 2022
Inventor: Dr. Matthias Grill
W02022038299 - Novel Psilocin derivates having prodrug properties
PCT Patent Application published
13. January 2022
Inventor: Dr. Matthias Grill
W02022008627 - Improved method for the production of lysergic acid diethylamide (LSD) and novel derivatives thereof
Collaboration with Compass Pathways
14. September 2021
COMPASS Pathways has acquired an intellectual property portfolio from MiHKAL, who will be working with COMPASS on an exclusive research project to develop new product candidates.
